These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 27556936)

  • 1. Predicting the Rate of Cognitive Decline in Alzheimer Disease: Data From the ICTUS Study.
    Canevelli M; Kelaiditi E; Del Campo N; Bruno G; Vellas B; Cesari M;
    Alzheimer Dis Assoc Disord; 2016; 30(3):237-42. PubMed ID: 27556936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Rapid Cognitive Decline in Patients with Mild-to-Moderate Alzheimer Disease: A Prospective Cohort Study with 12-Month Follow-Up Performed in Memory Clinics.
    Tchalla AE; Clément JP; Saulnier I; Beaumatin B; Lachal F; Gayot C; Bosetti A; Desormais I; Perrochon A; Preux PM; Couratier P; Dantoine T
    Dement Geriatr Cogn Disord; 2018; 45(1-2):56-65. PubMed ID: 29684916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and rate of cognitive decline in Alzheimer disease: implications for clinical trials.
    Bernick C; Cummings J; Raman R; Sun X; Aisen P
    Arch Neurol; 2012 Jul; 69(7):901-5. PubMed ID: 22431834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.
    Song X; Mitnitski A; Zhang N; Chen W; Rockwood K;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):71-8. PubMed ID: 23123510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.
    Sona A; Zhang P; Ames D; Bush AI; Lautenschlager NT; Martins RN; Masters CL; Rowe CC; Szoeke C; Taddei K; Ellis KA;
    Int Psychogeriatr; 2012 Feb; 24(2):197-204. PubMed ID: 21749739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
    Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
    JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease.
    Silvestrini M; Pasqualetti P; Baruffaldi R; Bartolini M; Handouk Y; Matteis M; Moffa F; Provinciali L; Vernieri F
    Stroke; 2006 Apr; 37(4):1010-5. PubMed ID: 16497984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.
    Vidal JS; Hanon O; Funalot B; Brunel N; Viollet C; Rigaud AS; Seux ML; le-Bouc Y; Epelbaum J; Duron E
    J Alzheimers Dis; 2016 Mar; 52(2):641-9. PubMed ID: 27031487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial.
    Sevigny JJ; Peng Y; Liu L; Lines CR
    Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):119-24. PubMed ID: 19949163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
    Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
    J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
    Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
    Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Cognitive and Functional Decline in Patients With Alzheimer Disease Dementia From Brazil.
    Oliveira FF; Chen ES; Smith MC; Bertolucci PH
    Alzheimer Dis Assoc Disord; 2016; 30(3):243-50. PubMed ID: 26523709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbleeds do not affect rate of cognitive decline in Alzheimer disease.
    van der Vlies AE; Goos JD; Barkhof F; Scheltens P; van der Flier WM
    Neurology; 2012 Aug; 79(8):763-9. PubMed ID: 22875093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.
    Henneges C; Reed C; Chen YF; Dell'Agnello G; Lebrec J
    J Alzheimers Dis; 2016; 52(3):1065-80. PubMed ID: 27079700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smell identification function as a severity and progression marker in Alzheimer's disease.
    Velayudhan L; Pritchard M; Powell JF; Proitsi P; Lovestone S
    Int Psychogeriatr; 2013 Jul; 25(7):1157-66. PubMed ID: 23597130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Jia J; Gauthier S; Pallotta S; Ji Y; Wei W; Xiao S; Peng D; Guo Q; Wu L; Chen S; Kuang W; Zhang J; Wei C; Tang Y
    Alzheimers Dement; 2017 May; 13(5):592-597. PubMed ID: 28238739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.